PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $504,000 | +70.3% | 133,380 | +72.2% | 0.00% | – |
| Q2 2021 | $296,000 | +504.1% | 77,434 | +305.7% | 0.00% | – |
| Q1 2021 | $49,000 | +4.3% | 19,088 | +25.2% | 0.00% | – |
| Q2 2020 | $47,000 | +11.9% | 15,242 | -17.6% | 0.00% | – |
| Q1 2020 | $42,000 | -61.8% | 18,498 | -38.9% | 0.00% | – |
| Q4 2019 | $110,000 | -63.2% | 30,286 | -65.5% | 0.00% | – |
| Q3 2019 | $299,000 | -26.5% | 87,755 | +1.4% | 0.00% | -100.0% |
| Q2 2019 | $407,000 | +65.4% | 86,562 | +18.0% | 0.00% | – |
| Q1 2019 | $246,000 | +85.0% | 73,372 | +47.0% | 0.00% | – |
| Q4 2018 | $133,000 | -1.5% | 49,904 | +107.0% | 0.00% | – |
| Q3 2018 | $135,000 | – | 24,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |